img

Global Pharma 4.0 Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharma 4.0 Market Insights, Forecast to 2034

Pharma 4.0 is a holistic operating model for pharmaceutical factories and supply chains of the future based on Industry 4.0 capabilities, digital maturity, and data integrity by design.Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. In practical terms, it means more connectivity, more productivity, simplified compliance, and the marshaling of production information to respond to problems as they emerge.
Market Analysis and InsightsGlobal Pharma 4.0 Market
Global Pharma 4.0 market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pharma 4.0 industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Pharma 4.0 market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Pharma 4.0 market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer Inc
Abbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Plc.
Lonza Group AG
GlaxoSmithKline plc.
Koninklijke Philips N.V.
Glatt GmbH
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Körber AG
Segment by Type
Cloud
On-premise

Segment by Application


Pharmaceutical Industry
IoT Industry
Medical Equipment Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Pharma 4.0 introduction, etc. Pharma 4.0 Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Pharma 4.0
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cloud
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Pharma 4.0 Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Industry
1.3.3 IoT Industry
1.3.4 Medical Equipment Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma 4.0 Market Perspective (2018-2029)
2.2 Global Pharma 4.0 Growth Trends by Region
2.2.1 Pharma 4.0 Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharma 4.0 Historic Market Size by Region (2018-2024)
2.2.3 Pharma 4.0 Forecasted Market Size by Region (2024-2029)
2.3 Pharma 4.0 Market Dynamics
2.3.1 Pharma 4.0 Industry Trends
2.3.2 Pharma 4.0 Market Drivers
2.3.3 Pharma 4.0 Market Challenges
2.3.4 Pharma 4.0 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharma 4.0 by Players
3.1.1 Global Pharma 4.0 Revenue by Players (2018-2024)
3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2018-2024)
3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharma 4.0, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Pharma 4.0 Market Concentration Ratio
3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2022
3.5 Global Key Players of Pharma 4.0 Head office and Area Served
3.6 Global Key Players of Pharma 4.0, Product and Application
3.7 Global Key Players of Pharma 4.0, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma 4.0 Breakdown Data by Type
4.1 Global Pharma 4.0 Historic Market Size by Type (2018-2024)
4.2 Global Pharma 4.0 Forecasted Market Size by Type (2024-2029)
5 Pharma 4.0 Breakdown Data by Application
5.1 Global Pharma 4.0 Historic Market Size by Application (2018-2024)
5.2 Global Pharma 4.0 Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharma 4.0 Market Size (2018-2029)
6.2 North America Pharma 4.0 Market Size by Type
6.2.1 North America Pharma 4.0 Market Size by Type (2018-2024)
6.2.2 North America Pharma 4.0 Market Size by Type (2024-2029)
6.2.3 North America Pharma 4.0 Market Share by Type (2018-2029)
6.3 North America Pharma 4.0 Market Size by Application
6.3.1 North America Pharma 4.0 Market Size by Application (2018-2024)
6.3.2 North America Pharma 4.0 Market Size by Application (2024-2029)
6.3.3 North America Pharma 4.0 Market Share by Application (2018-2029)
6.4 North America Pharma 4.0 Market Size by Country
6.4.1 North America Pharma 4.0 Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Pharma 4.0 Market Size by Country (2018-2024)
6.4.3 North America Pharma 4.0 Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pharma 4.0 Market Size (2018-2029)
7.2 Europe Pharma 4.0 Market Size by Type
7.2.1 Europe Pharma 4.0 Market Size by Type (2018-2024)
7.2.2 Europe Pharma 4.0 Market Size by Type (2024-2029)
7.2.3 Europe Pharma 4.0 Market Share by Type (2018-2029)
7.3 Europe Pharma 4.0 Market Size by Application
7.3.1 Europe Pharma 4.0 Market Size by Application (2018-2024)
7.3.2 Europe Pharma 4.0 Market Size by Application (2024-2029)
7.3.3 Europe Pharma 4.0 Market Share by Application (2018-2029)
7.4 Europe Pharma 4.0 Market Size by Country
7.4.1 Europe Pharma 4.0 Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Pharma 4.0 Market Size by Country (2018-2024)
7.4.3 Europe Pharma 4.0 Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharma 4.0 Market Size (2018-2029)
8.2 China Pharma 4.0 Market Size by Type
8.2.1 China Pharma 4.0 Market Size by Type (2018-2024)
8.2.2 China Pharma 4.0 Market Size by Type (2024-2029)
8.2.3 China Pharma 4.0 Market Share by Type (2018-2029)
8.3 China Pharma 4.0 Market Size by Application
8.3.1 China Pharma 4.0 Market Size by Application (2018-2024)
8.3.2 China Pharma 4.0 Market Size by Application (2024-2029)
8.3.3 China Pharma 4.0 Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pharma 4.0 Market Size (2018-2029)
9.2 Asia Pharma 4.0 Market Size by Type
9.2.1 Asia Pharma 4.0 Market Size by Type (2018-2024)
9.2.2 Asia Pharma 4.0 Market Size by Type (2024-2029)
9.2.3 Asia Pharma 4.0 Market Share by Type (2018-2029)
9.3 Asia Pharma 4.0 Market Size by Application
9.3.1 Asia Pharma 4.0 Market Size by Application (2018-2024)
9.3.2 Asia Pharma 4.0 Market Size by Application (2024-2029)
9.3.3 Asia Pharma 4.0 Market Share by Application (2018-2029)
9.4 Asia Pharma 4.0 Market Size by Region
9.4.1 Asia Pharma 4.0 Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Pharma 4.0 Market Size by Region (2018-2024)
9.4.3 Asia Pharma 4.0 Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharma 4.0 Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Pharma 4.0 Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Pharma 4.0 Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Pharma 4.0 Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Pharma 4.0 Introduction
11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2018-2024)
11.1.5 Pfizer Inc Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Pharma 4.0 Introduction
11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2018-2024)
11.2.5 Abbott Laboratories Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Pharma 4.0 Introduction
11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2018-2024)
11.3.5 GE Healthcare Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Pharma 4.0 Introduction
11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2018-2024)
11.4.5 Boston Scientific Recent Developments
11.5 Medtronic Plc.
11.5.1 Medtronic Plc. Company Details
11.5.2 Medtronic Plc. Business Overview
11.5.3 Medtronic Plc. Pharma 4.0 Introduction
11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2018-2024)
11.5.5 Medtronic Plc. Recent Developments
11.6 Lonza Group AG
11.6.1 Lonza Group AG Company Details
11.6.2 Lonza Group AG Business Overview
11.6.3 Lonza Group AG Pharma 4.0 Introduction
11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2018-2024)
11.6.5 Lonza Group AG Recent Developments
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Details
11.7.2 GlaxoSmithKline plc. Business Overview
11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2018-2024)
11.7.5 GlaxoSmithKline plc. Recent Developments
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Company Details
11.8.2 Koninklijke Philips N.V. Business Overview
11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2018-2024)
11.8.5 Koninklijke Philips N.V. Recent Developments
11.9 Glatt GmbH
11.9.1 Glatt GmbH Company Details
11.9.2 Glatt GmbH Business Overview
11.9.3 Glatt GmbH Pharma 4.0 Introduction
11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2018-2024)
11.9.5 Glatt GmbH Recent Developments
11.10 Vertex
11.10.1 Vertex Company Details
11.10.2 Vertex Business Overview
11.10.3 Vertex Pharma 4.0 Introduction
11.10.4 Vertex Revenue in Pharma 4.0 Business (2018-2024)
11.10.5 Vertex Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Pharma 4.0 Introduction
11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2018-2024)
11.11.5 Johnson & Johnson Recent Developments
11.12 Goodly Innovations
11.12.1 Goodly Innovations Company Details
11.12.2 Goodly Innovations Business Overview
11.12.3 Goodly Innovations Pharma 4.0 Introduction
11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2018-2024)
11.12.5 Goodly Innovations Recent Developments
11.13 QbDVision
11.13.1 QbDVision Company Details
11.13.2 QbDVision Business Overview
11.13.3 QbDVision Pharma 4.0 Introduction
11.13.4 QbDVision Revenue in Pharma 4.0 Business (2018-2024)
11.13.5 QbDVision Recent Developments
11.14 Electrosan
11.14.1 Electrosan Company Details
11.14.2 Electrosan Business Overview
11.14.3 Electrosan Pharma 4.0 Introduction
11.14.4 Electrosan Revenue in Pharma 4.0 Business (2018-2024)
11.14.5 Electrosan Recent Developments
11.15 GoSilico
11.15.1 GoSilico Company Details
11.15.2 GoSilico Business Overview
11.15.3 GoSilico Pharma 4.0 Introduction
11.15.4 GoSilico Revenue in Pharma 4.0 Business (2018-2024)
11.15.5 GoSilico Recent Developments
11.16 Smart Factory
11.16.1 Smart Factory Company Details
11.16.2 Smart Factory Business Overview
11.16.3 Smart Factory Pharma 4.0 Introduction
11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2018-2024)
11.16.5 Smart Factory Recent Developments
11.17 Körber AG
11.17.1 Körber AG Company Details
11.17.2 Körber AG Business Overview
11.17.3 Körber AG Pharma 4.0 Introduction
11.17.4 Körber AG Revenue in Pharma 4.0 Business (2018-2024)
11.17.5 Körber AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharma 4.0 Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cloud
Table 3. Key Players of On-premise
Table 4. Global Pharma 4.0 Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Pharma 4.0 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Pharma 4.0 Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Pharma 4.0 Market Share by Region (2018-2024)
Table 8. Global Pharma 4.0 Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Pharma 4.0 Market Share by Region (2024-2029)
Table 10. Pharma 4.0 Market Trends
Table 11. Pharma 4.0 Market Drivers
Table 12. Pharma 4.0 Market Challenges
Table 13. Pharma 4.0 Market Restraints
Table 14. Global Pharma 4.0 Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Pharma 4.0 Revenue Share by Players (2018-2024)
Table 16. Global Top Pharma 4.0 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2022)
Table 17. Global Pharma 4.0 Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Pharma 4.0 Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Pharma 4.0, Headquarters and Area Served
Table 20. Global Key Players of Pharma 4.0, Product and Application
Table 21. Global Key Players of Pharma 4.0, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Pharma 4.0 Revenue Market Share by Type (2018-2024)
Table 25. Global Pharma 4.0 Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Pharma 4.0 Revenue Market Share by Type (2024-2029)
Table 27. Global Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Pharma 4.0 Revenue Share by Application (2018-2024)
Table 29. Global Pharma 4.0 Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Pharma 4.0 Revenue Share by Application (2024-2029)
Table 31. North America Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Pharma 4.0 Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Pharma 4.0 Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Pharma 4.0 Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Pharma 4.0 Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Pharma 4.0 Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Pharma 4.0 Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Pharma 4.0 Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Pharma 4.0 Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Pharma 4.0 Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Pharma 4.0 Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Pharma 4.0 Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Pharma 4.0 Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Pharma 4.0 Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Pharma 4.0 Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pharma 4.0 Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pharma 4.0 Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pfizer Inc Company Details
Table 64. Pfizer Inc Business Overview
Table 65. Pfizer Inc Pharma 4.0 Product
Table 66. Pfizer Inc Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 67. Pfizer Inc Recent Developments
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Pharma 4.0 Product
Table 71. Abbott Laboratories Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 72. Abbott Laboratories Recent Developments
Table 73. GE Healthcare Company Details
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Pharma 4.0 Product
Table 76. GE Healthcare Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 77. GE Healthcare Recent Developments
Table 78. Boston Scientific Company Details
Table 79. Boston Scientific Business Overview
Table 80. Boston Scientific Pharma 4.0 Product
Table 81. Boston Scientific Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 82. Boston Scientific Recent Developments
Table 83. Medtronic Plc. Company Details
Table 84. Medtronic Plc. Business Overview
Table 85. Medtronic Plc. Pharma 4.0 Product
Table 86. Medtronic Plc. Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 87. Medtronic Plc. Recent Developments
Table 88. Lonza Group AG Company Details
Table 89. Lonza Group AG Business Overview
Table 90. Lonza Group AG Pharma 4.0 Product
Table 91. Lonza Group AG Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 92. Lonza Group AG Recent Developments
Table 93. GlaxoSmithKline plc. Company Details
Table 94. GlaxoSmithKline plc. Business Overview
Table 95. GlaxoSmithKline plc. Pharma 4.0 Product
Table 96. GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 97. GlaxoSmithKline plc. Recent Developments
Table 98. Koninklijke Philips N.V. Company Details
Table 99. Koninklijke Philips N.V. Business Overview
Table 100. Koninklijke Philips N.V. Pharma 4.0 Product
Table 101. Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 102. Koninklijke Philips N.V. Recent Developments
Table 103. Glatt GmbH Company Details
Table 104. Glatt GmbH Business Overview
Table 105. Glatt GmbH Pharma 4.0 Product
Table 106. Glatt GmbH Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 107. Glatt GmbH Recent Developments
Table 108. Vertex Company Details
Table 109. Vertex Business Overview
Table 110. Vertex Pharma 4.0 Product
Table 111. Vertex Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 112. Vertex Recent Developments
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Business Overview
Table 115. Johnson & Johnson Pharma 4.0 Product
Table 116. Johnson & Johnson Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 117. Johnson & Johnson Recent Developments
Table 118. Goodly Innovations Company Details
Table 119. Goodly Innovations Business Overview
Table 120. Goodly Innovations Pharma 4.0 Product
Table 121. Goodly Innovations Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 122. Goodly Innovations Recent Developments
Table 123. QbDVision Company Details
Table 124. QbDVision Business Overview
Table 125. QbDVision Pharma 4.0 Product
Table 126. QbDVision Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 127. QbDVision Recent Developments
Table 128. Electrosan Company Details
Table 129. Electrosan Business Overview
Table 130. Electrosan Pharma 4.0 Product
Table 131. Electrosan Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 132. Electrosan Recent Developments
Table 133. GoSilico Company Details
Table 134. GoSilico Business Overview
Table 135. GoSilico Pharma 4.0 Product
Table 136. GoSilico Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 137. GoSilico Recent Developments
Table 138. Smart Factory Company Details
Table 139. Smart Factory Business Overview
Table 140. Smart Factory Pharma 4.0 Product
Table 141. Smart Factory Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 142. Smart Factory Recent Developments
Table 143. Körber AG Company Details
Table 144. Körber AG Business Overview
Table 145. Körber AG Pharma 4.0 Product
Table 146. Körber AG Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 147. Körber AG Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharma 4.0 Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Pharma 4.0 Market Share by Type: 2022 VS 2029
Figure 3. Cloud Features
Figure 4. On-premise Features
Figure 5. Global Pharma 4.0 Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Pharma 4.0 Market Share by Application: 2022 VS 2029
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. IoT Industry Case Studies
Figure 9. Medical Equipment Industry Case Studies
Figure 10. Others Case Studies
Figure 11. Pharma 4.0 Report Years Considered
Figure 12. Global Pharma 4.0 Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Pharma 4.0 Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pharma 4.0 Market Share by Region: 2022 VS 2029
Figure 15. Global Pharma 4.0 Market Share by Players in 2022
Figure 16. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pharma 4.0 Revenue in 2022
Figure 18. North America Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Pharma 4.0 Market Share by Type (2018-2029)
Figure 20. North America Pharma 4.0 Market Share by Application (2018-2029)
Figure 21. North America Pharma 4.0 Market Share by Country (2018-2029)
Figure 22. United States Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Pharma 4.0 Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Pharma 4.0 Market Share by Type (2018-2029)
Figure 26. Europe Pharma 4.0 Market Share by Application (2018-2029)
Figure 27. Europe Pharma 4.0 Market Share by Country (2018-2029)
Figure 28. Germany Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Pharma 4.0 Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Pharma 4.0 Market Share by Type (2018-2029)
Figure 36. China Pharma 4.0 Market Share by Application (2018-2029)
Figure 37. Asia Pharma 4.0 Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Pharma 4.0 Market Share by Type (2018-2029)
Figure 39. Asia Pharma 4.0 Market Share by Application (2018-2029)
Figure 40. Asia Pharma 4.0 Market Share by Region (2018-2029)
Figure 41. Japan Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Pharma 4.0 Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Pharma 4.0 Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Pharma 4.0 Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Pharma 4.0 Market Share by Country (2018-2029)
Figure 51. Brazil Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Pfizer Inc Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 58. Abbott Laboratories Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 59. GE Healthcare Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 60. Boston Scientific Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 61. Medtronic Plc. Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 62. Lonza Group AG Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 63. GlaxoSmithKline plc. Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 64. Koninklijke Philips N.V. Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 65. Glatt GmbH Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 66. Vertex Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 67. Johnson & Johnson Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 68. Goodly Innovations Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 69. QbDVision Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 70. Electrosan Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 71. GoSilico Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 72. Smart Factory Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 73. Körber AG Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries